Publications

Insights into microbiome research 3: Who's there versus what are they doing?

Baranzini SE

Multiple sclerosis (Houndmills, Basingstoke, England), 2018

Protein network analysis reveals selectively vulnerable regions and biological processes in FTD.

Bonham LW, Steele NZR, Karch CM, Manzoni C, Geier EG, Wen N, Ofori-Kuragu A, Momeni P, Hardy J, Miller ZA, Hess CP, Lewis P, Miller BL, Seeley WW, Baranzini SE, Desikan RS, Ferrari R, Yokoyama JS

Neurology. Genetics, 2018

Insights into microbiome research 1: How to choose appropriate controls for a microbiome study in MS?

Baranzini SE

Multiple sclerosis (Houndmills, Basingstoke, England), 2018

Genome sequencing uncovers phenocopies in primary progressive multiple sclerosis.

Jia X, Madireddy L, Caillier S, Santaniello A, Esposito F, Comi G, Stuve O, Zhou Y, Taylor B, Kilpatrick T, Martinelli-Boneschi F, Cree BAC, Oksenberg JR, Hauser SL, Baranzini SE

Annals of neurology, 2018

Mononuclear cell transcriptome changes associated with dimethyl fumarate in MS

Arie R. Gafson, Kicheol Kim, Maria T. Cencioni, Wim van Hecke, Richard Nicholas, Sergio E. Baranzini, Paul M. Matthews

Neurology: Neuroimmunology & Neuroinflammation, 2018

Mononuclear cell transcriptome changes associated with dimethyl fumarate in MS.

Gafson AR, Kim K, Cencioni MT, van Hecke W, Nicholas R, Baranzini SE, Matthews PM

Neurology(R) neuroimmunology & neuroinflammation, 2018

Correction: Peroxisome proliferator-activated receptor (PPAR)a expression in T cells mediates gender differences in development of T cell-mediated autoimmunity.

Dunn SE, Ousman SS, Sobel RA, Zuniga L, Baranzini SE, Youssef S, Crowell A, Loh J, Oksenberg J, Steinman L

The Journal of experimental medicine, 2018

Multiple sclerosis.

Thompson AJ, Baranzini SE, Geurts J, Hemmer B, Ciccarelli O

Lancet (London, England), 2018

The microbiome and MS: The influence of the microbiota on MS risk and progression-Session chair summary.

Katz Sand I, Baranzini SE

Multiple sclerosis (Houndmills, Basingstoke, England), 2018

The Role of the Gut Microbiome in Multiple Sclerosis Risk and Progression: Towards Characterization of the "MS Microbiome".

Pröbstel AK, Baranzini SE

Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics, 2018

Pages